Company intelligence / Profile preview
PhytoMyco Research
Mysuru, Karnataka, Indiaphytomyco.in ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PhytoMyco Research is developing a portfolio of botanically derived drugs and nutraceuticals. Its lead candidate for diabetes is in late-stage development. Other programs target infectious diseases such as tuberculosis and drug-resistant bacteria, with all candidates originating from an extensive natural product library of over 16,000 phytochemicals sourced from indigenous Indian plants. The company leverages traditional medicine knowledge to accelerate development timelines.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious Diseases
- Modalities
- Small moleculeNatural product-based drugsBotanically derived products
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on PhytoMyco Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PhytoMyco Research.